Brown Advisory’s Acceleron Pharma Inc. XLRN Stock Holding History

Brown Advisory’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-472,473	Closed	-$81.3M	–	1309
2021 Q3	$81.3M	Buy	472,473 +9,370	+2%	+$1.61M	0.12%	144
2021 Q2	$58.1M	Buy	463,103 +22,683	+5%	+$2.85M	0.09%	175
2021 Q1	$59.7M	Buy	440,420 +12,889	+3%	+$1.75M	0.1%	159
2020 Q4	$54.7M	Buy	427,531 +6,819	+2%	+$872K	0.1%	156
2020 Q3	$47.3M	Buy	420,712 +5,228	+1%	+$588K	0.1%	146
2020 Q2	$39.6M	Buy	415,484 +20,443	+5%	+$1.95M	0.09%	153
2020 Q1	$35.5M	Buy	395,041 +3,923	+1%	+$353K	0.11%	147
2019 Q4	$20.7M	Buy	391,118 +11,951	+3%	+$634K	0.05%	246
2019 Q3	$15M	Buy	379,167 +13,323	+4%	+$526K	0.04%	266
2019 Q2	$15M	Buy	365,844 +2,003	+0.6%	+$82.3K	0.04%	274
2019 Q1	$16.9M	Buy	363,841 +40,483	+13%	+$1.89M	0.05%	277
2018 Q4	$14.1M	Sell	323,358 -206,995	-39%	-$9.01M	0.05%	279
2018 Q3	$30.4M	Buy	530,353 +18,147	+4%	+$1.04M	0.09%	205
2018 Q2	$24.9M	Buy	512,206 +7,529	+1%	+$365K	0.08%	219
2018 Q1	$19.7M	Buy	504,677 +28,806	+6%	+$1.13M	0.06%	233
2017 Q4	$20.2M	Buy	475,871 +15,829	+3%	+$672K	0.06%	235
2017 Q3	$17.2M	Buy	460,042 +25,118	+6%	+$937K	0.06%	242
2017 Q2	$13.2M	Buy	434,924 +6,000	+1%	+$182K	0.04%	275
2017 Q1	$11.4M	Buy	428,924 +74,687	+21%	+$1.98M	0.04%	272
2016 Q4	$9.04M	Buy	354,237 +30,465	+9%	+$777K	0.03%	299
2016 Q3	$11.7M	Buy	323,772 +26,506	+9%	+$959K	0.04%	268
2016 Q2	$10.1M	Buy	297,266 +13,078	+5%	+$444K	0.04%	280
2016 Q1	$7.5M	Buy	284,188 +835	+0.3%	+$22K	0.03%	306
2015 Q4	$13.8M	Buy	283,353 +16,370	+6%	+$798K	0.05%	226
2015 Q3	$6.65M	Buy	266,983 +17,802	+7%	+$443K	0.02%	321
2015 Q2	$7.88M	Sell	249,181 -18,023	-7%	-$570K	0.03%	298
2015 Q1	$10.2M	Buy	267,204 +105,264	+65%	+$4.01M	0.03%	275
2014 Q4	$6.31M	Buy	161,940 +152,616	+1,637%	+$5.95M	0.02%	318
2014 Q3	$282K	Buy	+9,324	New	+$282K	﹤0.01%	814